What is Siegfried Holding AG?
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
0QQO · Verdict
Moderate reward · moderate risk
0QQO stands out on cash flow and volatility, but watch the growth signal.
Based on 88% data coverage
0QQO · Verdict
1% free-cash-flow margin
Above average
Rev +2.6% CAGR · earnings +2.5%
13% net margin · 16% ROE
Model-based scoring. For information only — not financial advice.
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company is listed on the LSE in UK, with a market capitalisation of 321.05M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.